Lek Takeover: Novartis Still Intends to Publish Takeover Bid
Ljubljana, 27 September - Swiss pharmaceutical company Novartis intends to stick to its takeover bid for Slovenian drug-maker Lek, irrespective of Friday's failure of Lek shareholders to change their company's statute in order to facilitate the takeover. Lek confirmed that it was informed today by Novartis of its intention.
The rest of this news item is available to subscribers.
The news item consists of 529 characters (without spaces) or 107 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.